X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1998) 1998
Publication (147) 147
Book Review (28) 28
Book Chapter (20) 20
Newsletter (4) 4
Web Resource (4) 4
Conference Proceeding (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1663) 1663
male (1033) 1033
index medicus (791) 791
female (775) 775
adult (758) 758
fabry disease - pathology (712) 712
fabry disease (710) 710
middle aged (571) 571
enzyme replacement therapy (500) 500
fabry disease - genetics (436) 436
fabry disease - complications (429) 429
fabry disease - diagnosis (412) 412
fabry's disease (369) 369
enzymes (319) 319
alpha-galactosidase - genetics (283) 283
adolescent (281) 281
genetics & heredity (271) 271
alpha-galactosidase (242) 242
diagnosis (234) 234
fabry disease - drug therapy (232) 232
animals (223) 223
biopsy (219) 219
aged (218) 218
mutation (212) 212
fabry-disease (203) 203
child (191) 191
cardiomyopathy (183) 183
alpha-galactosidase - therapeutic use (181) 181
cardiac & cardiovascular systems (169) 169
fabry disease - enzymology (168) 168
fabry disease - physiopathology (168) 168
medicine, research & experimental (168) 168
fabry disease - metabolism (166) 166
kidney - pathology (165) 165
clinical neurology (160) 160
magnetic resonance imaging (155) 155
diagnosis, differential (153) 153
medicine & public health (153) 153
alpha-galactosidase - metabolism (150) 150
young adult (150) 150
mice (149) 149
pathology (141) 141
research (141) 141
disease (138) 138
globotriaosylceramide (138) 138
myocardium - pathology (138) 138
pediatrics (137) 137
microscopy, electron (135) 135
care and treatment (134) 134
health aspects (132) 132
prevalence (127) 127
medicine (126) 126
urology & nephrology (126) 126
phenotype (124) 124
skin - pathology (117) 117
analysis (115) 115
neurosciences (115) 115
clinical-manifestations (111) 111
fabry disease - therapy (109) 109
internal medicine (109) 109
endocrinology & metabolism (107) 107
risk factors (103) 103
genetics (102) 102
involvement (100) 100
biochemistry & molecular biology (98) 98
heterozygote (98) 98
enzyme-replacement therapy (95) 95
pedigree (95) 95
manifestations (94) 94
patients (94) 94
treatment outcome (94) 94
disease progression (91) 91
trihexosylceramides - metabolism (91) 91
mutations (90) 90
isoenzymes - therapeutic use (89) 89
stroke (89) 89
alpha-galactosidase-a (88) 88
heart (86) 86
alpha-galactosidase a (85) 85
females (85) 85
hypertrophic cardiomyopathy (85) 85
brain - pathology (83) 83
echocardiography (83) 83
genetic aspects (83) 83
alpha-galactosidase - blood (81) 81
medicine, general & internal (81) 81
child, preschool (80) 80
medical research (78) 78
safety (78) 78
disease models, animal (77) 77
heart diseases (76) 76
outcome survey (76) 76
pain (76) 76
physiological aspects (75) 75
human genetics (74) 74
usage (73) 73
α-galactosidase a (73) 73
children (72) 72
research article (72) 72
metabolic diseases (69) 69
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1829) 1829
French (59) 59
Japanese (37) 37
German (33) 33
Spanish (21) 21
Russian (8) 8
Hungarian (6) 6
Polish (6) 6
Chinese (5) 5
Italian (5) 5
Czech (3) 3
Norwegian (3) 3
Dutch (2) 2
Finnish (2) 2
Croatian (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Academy of Medicine Singapore, ISSN 0304-4602, 03/2009, Volume 38, Issue 3, pp. 240 - 250
Journal Article
Circulation, ISSN 0009-7322, 05/2009, Volume 119, Issue 19, pp. 2561 - 2567
Background-In classic Fabry patients, accelerated coronary atherosclerosis and left ventricular hypertrophy manifest in the fourth decade; however, signs of... 
Microcirculation | Pathology | Hypercholesterolemia | Ischemia | Hypertrophy | CARDIAC & CARDIOVASCULAR SYSTEMS | pathology | CHOLESTEROL | hypertrophy | CARDIOMYOPATHY | INVOLVEMENT | ATHEROSCLEROSIS | LOW-DENSITY LIPOPROTEIN | microcirculation | hypercholesterolemia | ALPHA-GALACTOSIDASE-A | ischemia | GLYCOSPHINGOLIPIDS | SERUM-LIPOPROTEINS | PERIPHERAL VASCULAR DISEASE | AGALSIDASE-ALPHA | ACCUMULATION | HEMATOLOGY | Recombinant Proteins - therapeutic use | alpha-Galactosidase - therapeutic use | Capillaries - pathology | Trihexosylceramides - analysis | Inclusion Bodies - chemistry | Humans | Lysosomes - enzymology | Male | Endocardium - pathology | Endothelium, Vascular - chemistry | Young Adult | Clinical Trials, Phase III as Topic | Adult | Female | Trihexosylceramides - metabolism | Inclusion Bodies - ultrastructure | Double-Blind Method | Capillaries - chemistry | Coronary Artery Disease - prevention & control | Fabry Disease - complications | Coronary Disease - etiology | Randomized Controlled Trials as Topic | Myocytes, Cardiac - pathology | Coronary Disease - pathology | Coronary Disease - prevention & control | Endocardium - ultrastructure | Biopsy | Adolescent | Coronary Disease - drug therapy | Myocytes, Cardiac - metabolism | Endothelium, Vascular - pathology | Prevention | Care and treatment | Heart enlargement | Atherosclerosis | Physiological aspects | Development and progression | Dosage and administration | Research | Recombinant molecules | Fabry's disease | Alpha galactosidases
Journal Article
Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 09/2016, Volume 8, Issue 355, pp. 355ra118 - 355ra118
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 03/2011, Volume 79, Issue 6, pp. 663 - 670
Journal Article